Latest Financials News

Powerhouse Ventures Limited reports a robust quarter with an 18% increase in net tangible assets and a standout 35.1% return from its Aliwa Alpha Fund, while preparing to launch a new Critical Infrastructure Opportunities Fund focused on AI and Quantum technologies.

Theta Gold Mines has mobilised contractors and begun civil works at its TGME Gold Mine Project, advancing steadily toward plant commissioning by the end of 2026 and production in early 2027.

MA Financial Group has reported a surge in assets under management and loan book growth alongside a major $525 million property acquisition, signaling robust momentum across its financial services divisions.

Axiom Properties Limited and Securexchange have teamed up to launch Settlement Advance, a financial solution allowing property sellers to access up to $350,000 of their home equity before settlement, streamlining the property transaction process.

Tigers Realm Coal's planned sale of its Russian subsidiaries faces ongoing delays due to regulatory hurdles and buyer demands for further price cuts, leaving the transaction in limbo and the company suspended from ASX trading.

Astral Resources reports robust assay results from its Theia Deposit in-fill drilling program, reinforcing the potential for a profitable starter pit at its Mandilla Gold Project. Ongoing diamond drilling and regional exploration at Feysville aim to further unlock value.

ReNerve Limited reported a 38% increase in quarterly sales driven by the launch of its EmpliQ product range and ongoing development of advanced nerve repair technologies. The company’s cash position remains solid as it prepares for upcoming clinical trials.

Woodside Energy Group has sealed a strategic partnership with US infrastructure giant Williams, selling stakes in Louisiana LNG and Driftwood Pipeline for $378 million, accelerating the project’s path to first LNG in 2029.

Tivan Limited has made significant strides in its critical minerals portfolio, establishing a key joint venture, acquiring the Molyhil Project, raising $15 million, and commencing drilling at Sandover. These developments underscore its growing role in Australia’s strategic minerals sector.

Anatara Lifesciences reports steady progress in its anti-obesity pre-clinical studies with results expected by year-end, while preparing its GaRP gastrointestinal health data for publication amid ongoing commercial talks. The company also announces a key board appointment and a $1.2 million capital raise.

Lumos Diagnostics reported steady quarterly revenue with a 300% surge in product sales, driven by its flagship FebriDx® test. The company inked a landmark US$317 million exclusive U.S. distribution agreement and awaits FDA feedback on its CLIA waiver application.

Insurance Australia Group (IAG) reported strong FY25 results and upgraded its FY26 guidance, reflecting the completed RACQ acquisition and ongoing strategic growth initiatives.